logo
Plus   Neg
Share
Email

Aerpio Pharma: TIME-2b Study With AKB-9778 Fails To Meet Primary Endpoint

Aerpio Pharmaceuticals, Inc. (ARPO) announced top-line results from the company's TIME-2b study, a Phase 2b clinical trial designed to assess the efficacy and safety of lead candidate, AKB-9778, for patients with moderate to severe non-proliferative diabetic retinopathy. The company said the administration of AKB-9778 twice daily did not meet the study's primary endpoint of the percentage of patients with an improvement of two or more steps in the study eye diabetic retinopathy severity score compared to placebo.

AKB-9778 did show encouraging data in a number of prespecified, key secondary endpoints, consistent with the observations in the prior Phase 2a trial, the company noted. AKB-9778 was found to be safe and well-tolerated in the patient population through 48 weeks of twice-daily dosing.

"While we are disappointed in the primary endpoint results of this study, we are nevertheless encouraged by the fact that several other promising findings observed in our prior 3-month Phase 2a trial have been prospectively confirmed in this 1-year trial. We and our clinical advisors believe that collectively these data support a potentially important role of the Tie2 pathway for the treatment of diabetic complications, as well as for open angle glaucoma. After a full analysis of the study data, we plan to provide an update on the status of the NPDR program," said Stephen Hoffman, CEO of Aerpio.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Norwex has announced voluntary recall of about 58,000 rubber brooms due to laceration hazard. According to the company, handles of the recalled brooms can break in half, exposing a metal inner rim, posing a laceration hazard to the user. The recall involves extendable indoor/outdoor white rubber... Amazon.com Inc. has expanded its AmazonFresh grocery delivery service to three new cities. Beginning today, Amazon Prime members in Houston, Minneapolis and Phoenix can shop thousands of products, ranging from meat and seafood to fresh produce and everyday essentials. The groceries will be delivered to their homes in two hours or less, with options for one-hour and two-hour delivery. Piping Rock Health Products issued a recall for about 18,600 units of wintergreen essential oil due to poisoning risk for children if they ingest it. However, the company has not received reports of any incidents or injuries so far. The recall involves Piping Rock wintergreen essential oil packaged in glass amber dropper bottles having a black cap and a yellow, red and green label.
Follow RTT